OnKure Therapeutics Ownership | Who Owns OnKure Therapeutics?

OnKure Therapeutics Ownership Summary

OnKure Therapeutics is owned by 75.65% institutional investors, 1.73% insiders, and 22.63% retail investors. Acorn capital advisors is the largest institutional shareholder, holding 21.02% of OKUR shares.

OKUR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	OnKure Therapeutics	75.65%	1.73%	22.63%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Acorn capital advisors	2.84M	21.02%	$7.81M
Shay capital	917.93K	6.79%	$2.52M
Vanguard group	678.23K	5.02%	$1.87M
Highbridge capital management	650.22K	4.81%	$1.79M
Vestal point capital, lp	635.00K	4.70%	$1.75M
Blackrock funding, inc. /de	564.84K	4.18%	$1.55M
Stepstone group lp	491.94K	3.64%	$1.35M
Cantor fitzgerald, l. p.	491.86K	3.64%	$1.35M
Nea management company	478.55K	3.54%	$1.32M
Carlyle group	269.89K	2.00%	$742.21K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Acorn capital advisors	2.84M	3.96%	$7.81M
Stepstone group lp	491.94K	0.64%	$1.35M
Rangeley capital	155.49K	0.37%	$427.60K
Shay capital	917.93K	0.22%	$2.52M
Prosight management, lp	267.96K	0.17%	$736.89K
Aldebaran capital	44.00K	0.11%	$120.99K
Vestal point capital, lp	635.00K	0.08%	$1.75M
Highbridge capital management	650.22K	0.08%	$1.79M
Nea management company	478.55K	0.07%	$1.32M
Aisling capital management lp	88.61K	0.05%	$243.67K

Top Buyers

Holder	Shares	% Assets	Change
Shay capital	917.93K	0.22%	135.89K
Rangeley capital	155.49K	0.37%	125.59K
Prosight management, lp	267.96K	0.17%	108.27K
Renaissance	175.75K	0.00%	53.11K
Gsa capital partners llp	59.22K	0.01%	37.46K

Top Sellers

Holder	Shares	% Assets	Change
Cormorant asset management, lp	-	-	-1.84M
Perceptive advisors	-	-	-1.00M
Samsara biocapital	-	-	-824.15K
Affinity asset advisors	-	-	-347.99K
Ikarian capital	-	-	-253.75K

New Positions

Holder	Shares	% Assets	Change	Value
Fmr	50.00	-	50.00	$138.00

Sold Out

Holder	Change
Adar1 capital management	-10.00K
Xtx topco	-10.64K
Bailard	-14.24K
Qube research	-18.66K
Landscape capital management	-41.05K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	42	-8.70%	10,219,608	5.81%	75	1.48%	17	-19.05%	12	-7.69%
Jun 30, 2025	48	4.35%	10,776,588	-9.78%	79	1.01%	23	-50.00%	13	-
Mar 31, 2025	2	-	710,559	-	5	-	2	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 22, 2025	Saccomano Nicholas A	President and CEO	Sell	$230.87
Sep 22, 2025	Leverone Jason A.	Chief Financial Officer	Sell	$794.92
Jun 23, 2025	Saccomano Nicholas A	President and CEO	Sell	$209.81
Jun 23, 2025	Leverone Jason A.	Chief Financial Officer	Sell	$722.41
May 15, 2025	Cormorant Asset Management, LP	Former 10% Owner	Sell	$3.36M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	2
2025 Q2	2	8
2025 Q1	-	-
2024 Q4	-	-

OKUR Ownership FAQ

Who Owns OnKure Therapeutics?

OnKure Therapeutics shareholders are primarily institutional investors at 75.65%, followed by 1.73% insiders and 22.62% retail investors. The average institutional ownership in OnKure Therapeutics's industry, Biotech Stocks , is 45.24%, which OnKure Therapeutics exceeds.

Who owns the most shares of OnKure Therapeutics?

OnKure Therapeutics’s largest shareholders are Acorn capital advisors (2.84M shares, 21.02%), Shay capital (917.93K shares, 6.79%), and Vanguard group (678.23K shares, 5.02%). Together, they hold 32.84% of OnKure Therapeutics’s total shares outstanding.

Does Blackrock own OnKure Therapeutics?

BlackRock is not among the top 10 institutional shareholders of OnKure Therapeutics.

Who is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested?

Acorn capital advisors is OnKure Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.96% of its assets in 2.84M OnKure Therapeutics shares, valued at 7.81M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools